SCHEMBL9300865

SCHEMBL9300865

OC(COc1ccc(Cl)c(Cl)c1)CN1CCN(CCCC(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
L3MBTL1 Q9Y468 1/20 0.52
KMT2A Q03164 4/20 0.52
MEN1 O00255 3/20 0.52
CACNA1G O43497 3/20 0.52
KCNH2 Q12809 3/20 0.52
ALDH1A1 P00352 3/20 0.51
HRH1 P35367 1/20 0.49
CCR3 P51677 1/20 0.49
MAPT P10636 3/20 0.49
USP2 O75604 1/20 0.49
HTT P42858 1/20 0.49
TP53 P04637 1/20 0.48
LMNA P02545 1/20 0.48
GLA P06280 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301460 0.91 CACNA1G (0.62) KMT2AMEN1CACNA1GKCNH2ALDH1A1
SCHEMBL9301847 0.88 CACNA1G (0.64) KMT2ACACNA1GKCNH2
SCHEMBL9303300 0.86 L3MBTL1 (0.70) KDM4EL3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL9193205 0.84 L3MBTL1 (0.59) KDM4EL3MBTL1KMT2AMEN1CACNA1G
SCHEMBL9192429 0.83 KCNH2 (0.64) KDM4EL3MBTL1KMT2ACACNA1GKCNH2
SCHEMBL9301892 0.81 KMT2A (0.67) KDM4EL3MBTL1KMT2AMEN1CACNA1G
SCHEMBL9302474 0.81 L3MBTL1 (0.64) KDM4EL3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL9189672 0.80 CACNA1G (0.60) KMT2AMEN1CACNA1GKCNH2MAPT
SCHEMBL10379764 0.79 L3MBTL1 (0.62) KDM4EL3MBTL1KMT2AMEN1CACNA1G
SCHEMBL9302848 0.79 L3MBTL1 (0.74) KDM4EL3MBTL1KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5342839-A Useful for therapy of oxygen deficiency diseases of the brain BASF AKTIENGESELLSCHAFT (DE) 1994-08-30 US disclosed